The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment

dc.creator	Kovač, Mirjana
dc.creator	Pruner, Iva
dc.creator	Kovac, Z.
dc.creator	Tomasević, Z.
dc.creator	Nesković-Konstantinović, Z.
dc.creator	Đorđević, Valentina
dc.creator	Radojković, Dragica
dc.date.accessioned	2022-11-15T14:25:23Z
dc.date.available	2022-11-15T14:25:23Z
dc.date.issued	2014
dc.identifier.issn	0049-3848
dc.identifier.uri	https://imagine.imgge.bg.ac.rs/handle/123456789/711
dc.publisher	Pergamon-Elsevier Science Ltd, Oxford
dc.rights	restrictedAccess
dc.source	Thrombosis Research
dc.title	The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment	en
dc.type	conferenceObject
dc.rights.license	ARR
dc.citation.epage	S103
dc.citation.other	133(): S103-S103
dc.citation.rank	M23
dc.citation.spage	S103
dc.citation.volume	133
dc.identifier.doi	10.1016/S0049-3848(14)50326-X
dc.identifier.wos	000338292900294
dc.type.version	publishedVersion